Browsing by Author "Kesic, V. (6701664626)"
Now showing 1 - 5 of 5
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(2013) ;Peccatori, F.A. (7004514394) ;Azim, Jr. (23984411900) ;Orecchia, R. (7005099958) ;Hoekstra, H.J. (36038081900) ;Pavlidis, N. (35461486500) ;Kesic, V. (6701664626)Pentheroudakis, G. (56230606500)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication Epidemiology of cancer of the female genital organs in Yugoslavia(1988) ;Sulovic, V. (7006602555)Kesic, V. (6701664626)[No abstract available] - Some of the metrics are blocked by yourconsent settings
Publication ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up(2016) ;Colombo, Nicoletta (7005656356) ;Creutzberg, C. (6701531876) ;Amant, F. (7004842517) ;Bosse, T. (8734705700) ;González-Martón, A. (57160475100) ;Ledermann, J. (7007134127) ;Marth, C. (7005288143) ;Nout, R. (7801614382) ;Querleu, D. (7102704380) ;Mirza, M.R. (7102855234) ;Sessa, C. (56250953800) ;Abal, M. (6602357400) ;Altundag, O. (6603767389) ;Banerjee, S. (55433897700) ;Casado, A. (7005832814) ;De Agustín, L.C. (57160426500) ;Cibula, D. (7006225985) ;Del Campo, J.-M. (57196690838) ;Emons, G. (35562770700) ;Goffin, F. (7004512023) ;González-Martín, A. (22953696600) ;Greggi, S. (7004646555) ;Haie-Meder, C. (57209429810) ;Katsaros, D. (7005894742) ;Kesic, V. (6701664626) ;Kurzeder, C. (6507625682) ;Lax, S. (7004374578) ;Lécuru, F. (55400009400) ;Levy, T. (7005868550) ;Lorusso, D. (57192342135) ;Mäenpää, J. (56078798700) ;Matias-Guiu, X. (7005317716) ;Morice, P. (35479744900) ;Nijman, H.W. (7005171364) ;Powell, M. (8134383300) ;Reed, N. (35941546100) ;Rodolakis, A. (7006527228) ;Salvesen, H. (7004474802) ;Sehouli, J. (7003518921) ;Taylor, A. (56308380600) ;Westermann, A. (6701321974)Zeimet, A.G. (7006038361)The first joint European Society for Medical Oncology (ESMO), European SocieTy for Radiotherapy & Oncology (ESTRO) and European Society of Gynaecological Oncology (ESGO) consensus conference on endometrial cancer was held on 11-13 December 2014 in Milan, Italy, and comprised a multidisciplinary panel of 40 leading experts in the management of endometrial cancer. Before the conference, the expert panel prepared three clinically relevant questions about endometrial cancer relating to the following four areas: prevention and screening, surgery, adjuvant treatment and advanced and recurrent disease. All relevant scientific literature, as identified by the experts, was reviewed in advance. During the consensus conference, the panel developed recommendations for each specific question and a consensus was reached. Results of this consensus conference, together with a summary of evidence supporting each recommendation, are detailed in this article. All participants have approved this final article. © The Author 2015. - Some of the metrics are blocked by yourconsent settings
Publication European consensus statement on essential colposcopy(2021) ;Redman, C.W.E. (21035589800) ;Kesic, V. (6701664626) ;Cruickshank, M.E. (7005752163) ;Gultekin, M. (6701502096) ;Carcopino, X. (16052319200) ;Castro Sanchez, M. (6508312168) ;Grigore, M. (6603422593) ;Jakobsson, M. (23027366500) ;Kuppers, V. (6701388251) ;Pedro, A. (58433479400) ;Reich, O. (7006151327) ;Leeson, S. (57908429500) ;Tabuica, U. (57219947237) ;Zodzika, J. (14010574800) ;Ciavattini, A. (7003495130) ;Jach, R. (19835722000) ;Katsyuba, M. (57219945844) ;Koiss, R. (35737352900) ;Martin-Hirsch, P. (57203223829) ;Tjalma, W.A. (7005898765)Nieminen, P. (7103275437)This European consensus statement on essential colposcopy provides standards for the general colposcopist seeing women referred for colposcopy with an abnormal cervical screening test (including cytology and HPV tests) or with a clinically suspicious cervix. The article gives guidance regarding the aims and conduct of colposcopy. Recommendations are provided on colposcopy technique, the management of common colposcopy issues, treatment and follow-up of after treatment of CIN or early stage cervical. Colposcopists should make an informed decision on the management of each individual that is referred and organize appropriate follow-up. Cervical cancer is still a major health issue and the quality of care can only improve if there is a structured guidance for women with an abnormal smear or suspicious cervix. © 2020 - Some of the metrics are blocked by yourconsent settings
Publication European consensus statement on expert colposcopy(2023) ;McGee, A.E. (57808941400) ;Alibegashvili, T. (36871728500) ;Elfgren, K. (6602235101) ;Frey, B. (58582859300) ;Grigore, M. (6603422593) ;Heinonen, A. (55661595000) ;Jach, R. (19835722000) ;Jariene, K. (6507045990) ;Kesic, V. (6701664626) ;Küppers, V. (6701388251) ;Kyrgiou, M. (55912711700) ;Leeson, S. (57908429500) ;Louwers, J. (25922993100) ;Mazurec, M. (6503868391) ;Mergui, J. (7005073607) ;Pedro, A. (58433479400) ;Šavrova, A. (58582859400) ;Siegler, E. (7003904560) ;Tabuica, U. (57219947237) ;Trojnarska, D. (57210442069) ;Trzeszcz, M. (56085526000) ;Turyna, R. (24177713100) ;Volodko, N. (6602969260)Cruickshank, M.E. (7005752163)Background: Following the publication of the European consensus statement on standards for essential colposcopy in 2020, the need for standards relating to more complex and challenging colposcopy practice was recognised. These standards relate to colposcopy undertaken in patients identified through cervical screening and tertiary referrals from colposcopists who undertake standard colposcopy only. This set of recommendations provides a review of the current literature and agreement on care for recognised complex cases. With good uptake of human papillomavirus (HPV) immunisation, we anticipate a marked reduction in cervical disease over the next decade. Still, the expert colposcopist will continue to be vital in managing complex cases, including previous cervical intraepithelial neoplasia (CIN)/complex screening histories and multi-zonal disease. Aims: To provide expert guidance on complex colposcopy cases through published evidence and expert consensus. Material & methods: Members of the EFC and ESGO formed a working group to identify topics considered to be the remit of the expert rather than the standard colposcopy service. These were presented at the EFC satellite meeting, Helsinki 2021, for broader discussion and finalisation of the topics. Results & discussion: The agreed standards included colposcopy in pregnancy and post-menopause, investigation and management of glandular abnormalities, persistent high-risk HPV+ with normal/low-grade cytology, colposcopy management of type 3 transformation zones (TZ), high-grade cytology and normal colposcopy, colposcopy adjuncts, follow-up after treatment with CIN next to TZ margins and follow-up after treatment with CIN with persistent HPV+, and more. These standards are under review to create a final paper of consensus standards for dissemination to all EFC and ESGO members. © 2023 The Author(s)
